1 / 4

European Injection Pen Market Trends, Size, Competitive Analysis and Forecast 2020-2026

The European injection pen market is projected to grow at a CAGR of 7.4% during the forecast period (2020-2026). The growth of the market in the region is attributed to the presence of the key players and a broad range of products offered by them.

mansi3210
Télécharger la présentation

European Injection Pen Market Trends, Size, Competitive Analysis and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research European Injection Pen Market, Size, Share, Analysis Report & Forecast to 2026 Request a Free Sample of our European Injection Pen Market: https://www.omrglobal.com/request- sample/european-injection-pen-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The European injection pen market is anticipated to grow at a CAGR of 7.4% over the forecast period (2020-2026). The key factors that drive the growth of the market in the region include easy availability of these devices in the region owing to the presence of key players such as Sanofi SA, Novo Nordisk AS, F. Hoffmann-La Roche Ltd. among many others which are pioneers in innovation, design, and manufacture of the injection pen. Some of the instances of the injection pen provided by the companies include the AllStar Pro pen injector which is a reusable pen injector for the drug delivery to the patient. Further, Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus are connected pens are reusable and include a tiny screen that displays the last dose that is approved in Europe (CE marked) for the use. Hence, this is likely to drive the growth of the European injection pen industry over the forecast period. A full Report of European Injection Pen Market is Available at: https://www.omrglobal.com/industry- reports/european-injection-pen-market The major countries of Europe including the UK, France, Germany, Italy, Spain, and the Rest of Europe support the market growth. Increasing cases of diabetes in these countries has more individuals taking insulin, which could also be self-taken using an insulin pen. As per the Diabetes UK, in 2019, there were almost 3.7 million people who were diagnosed with diabetes in the country; IDF recorded more than 3 million cases of diabetes in France in 2019; as per a 2019 report by the German Diabetes Center (DDZ), more than 7.2% of the population in Germany suffer from diabetes. Thus, this creates a scope for market growth in the major economies of Europe over the forecast period. Request a Free Sample of our European Injection Pen Market: https://www.omrglobal.com/request- sample/european-injection-pen-market Market Coverage       Market number available for – 2019-2026 Base year- 2019 Forecast period- 2020-2026 Segment Covered- By Type, By Disorder Type Regions Covered- Europe Competitive Landscape- F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, AstraZeneca Plc, Bayer AG, Novo Nordisk A/S, and Sanofi SA Key questions addressed by the report       What is the market growth rate? Which segment dominates the market in the base year? Which segment will project the fastest growth in the market? Who is the leader in the market? How players are addressing challenges to sustain growth? Where is the investment opportunity? Europe Injection Pen Market – Segmentation

  3. By Type   Reusable Disposable By Disorder Type     Autoimmune Disorders Hormonal Disorders Orphan Diseases Others Europe Injection Pen Market – Countries Covered      UK Germany France Italy Rest of Europe Company Profiles                    AstraZeneca Plc Overview AstraZeneca Plc in Europe AstraZeneca Plc in Injection Pen Landscape Recent Developments Bayer AG Biocorp Production SA Eli Lilly and Co. F. Hoffmann-La Roche Ltd. Gerresheimer AG GlaxoSmithKline Plc Haselmeier GmbH Merck KGaA Mylan N.V. Novartis International AG Novo Nordisk A/S Owen Mumford Ltd. Sanofi SA Ypsomed Holding AG For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/european-injection-pen-market

  4. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related